‹ All Posts
Pyrifera Investment Advisors

9th Nov · SEBI Registration INH000020466

Vinati organics plans 500 crore specialty chemical capex

Vinati Organics announced a ₹500 crore capital expenditure plan to develop new specialty chemicals for fragrances, personal care, and water treatment. The company is also exploring an additional ₹500 crore expansion pending land acquisition. The ₹500 crore capex will be funded entirely through internal accruals and commercialized within two years. This matters because it diversifies the company's revenue beyond its core ATBS and Butyl Phenol segments into higher-margin specialty applications. I am watching the Q3 FY27 earnings call in January 2027 for updates on the land acquisition timeline for the secondary ₹500 crore project and the sequential volume recovery metrics in the ATBS segment. The market currently prices Vinati Organics purely on its legacy ATBS volume cycles, viewing new capex as a distant, margin-dilutive distraction. What the consensus misses is the structural operating leverage this specific expansion enables. Step one: funding entirely through internal accruals proves robust cash generation without balance sheet debt drag. Step two: targeting fragrances and water treatment leverages existing chemical competencies, minimizing R&D failure risk. Step three: the projected 24%-25% EBITDA margin for FY27, despite input cost pressures, demonstrates exceptional pricing power that will only amplify as the new ₹100 crore MEHQ and BHA revenue streams scale. The market misprices this as routine capacity addition, ignoring the compounding return on capital employed (ROCE) from a highly integrated, debt-free specialty chemical platform. Accumulate for long-term specialty chemical margin expansion. Disclosure: I do not hold positions in this stock. This is for educational purposes only and does not constitute investment advice. VINATIORGA

#WatchOutFor#StockInNews
1,448 likes·70 comments